Related Experiment Video
Updated: Jul 29, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Proteomic approach to studying Parkinson's disease
1University of Washington and Institute for Systems Biology, Seattle, WA. zhangj@u.washington.edu
Molecular Neurobiology
|June 8, 2004
Summary
Parkinson's disease involves neuron loss and Lewy bodies, with alpha-synuclein aggregation playing a key role. This review proposes a proteomic approach to understand aggregation, Lewy body formation, and neurodegeneration mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Parkinson's disease (PD) is an age-related neurodegenerative disorder.
- Pathologically, PD involves dopaminergic neuron loss in the substantia nigra and Lewy body formation.
- Alpha-synuclein aggregation is implicated in Lewy body formation and neurodegeneration, but mechanisms are unclear.
Purpose of the Study:
- To review current research on alpha-synuclein aggregation and related cellular dysfunctions in Parkinson's disease.
- To propose a proteomic strategy for investigating the mechanisms driving alpha-synuclein aggregation, Lewy body formation, and neurodegeneration.
Main Methods:
- Literature review of current research fields.
- Proposal of a proteomic approach to study protein interactions and aggregation pathways.
Main Results:
- Mitochondrial dysfunction, oxidative stress, and ubiquitin-proteasome system impairment are linked to alpha-synuclein aggregation.
- The relationship between these factors and neurodegeneration, with or without Lewy bodies, requires further investigation.
Conclusions:
- Understanding the interplay between cellular dysfunctions and alpha-synuclein aggregation is crucial for elucidating Parkinson's disease pathogenesis.
- A proteomic approach offers a promising avenue to uncover the molecular mechanisms underlying PD-related neurodegeneration.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...